AK Medical Holdings Limited disclosed that it bought back 50,000 ordinary shares on 5 October 2026 through on-market transactions at an average price of HK$4.665 per share, for a total consideration of HK$0.23 million.

The repurchased shares, representing 0.0046% of AK Medical’s issued share capital (excluding treasury shares) prior to the transaction, will be held as treasury shares. As a result, the company’s treasury stock increased from 32.94 million to 32.99 million shares. The number of issued shares outstanding (excluding treasury shares) declined to 1.07699 billion, while the total issued share count remained unchanged at 1.10998 billion.

The transaction was executed under the general mandate granted on 17 June 2026, which authorises repurchases of up to 112.46 million shares. Cumulatively, 48.56 million shares—equivalent to 4.32% of the share base on the mandate date—have been repurchased under this authority.

In line with Hong Kong listing rules, AK Medical is subject to a moratorium on new share issues or treasury-share disposals until 4 November 2026. The board affirmed that all regulatory and procedural requirements for the repurchase have been satisfied.